Breast cancer

October 2, 2020

Ongoing Trial: In the TMIST mammography trial, nearly 20% of the volunteers are Black women, thanks to a successful recruitment strategy

The TMIST breast cancer screening trial continues to enroll women during the COVID-19 pandemic. This article describes ways trial leaders and clinical staff are making TMIST available to women in minority communities.
October 2, 2020

Trial Results: A 10-minute MRI proves useful in women with dense breasts at average risk of developing breast cancer

Dr. Christopher Comstock, a radiologist who specializes in breast cancer imaging, talks about the results of clinical trial EA1141 and how it will hopefully give far more women access to a powerful tool in the fight against breast cancer
October 2, 2020

Trial Results: For women with breast cancer in the TAILORx trial, cognitive decline from chemo was early and abrupt but did not get worse over time. Cognition also declined in the group on hormone therapy alone.

Cognitive loss—or ‘brain fog’—involves memory problems, a lack of mental clarity, and difficulty keeping one’s focus. Cancer-related brain fog is common during treatment. This study dispels the idea that it is only from chemotherapy.